Cozadd Bruce C 的 Form 4 申報
Jazz Pharmaceuticals plc（JAZZ），2025/12/1 申報
- 申報編號
- 0001193210-25-000011
- 申報時間
- 2025/12/1
- 交易日
- 2025/11/26
- 申報延遲
- 5 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 6 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $1,378 萬。交易後 5 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Cozadd Bruce CCIK 0001193210 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/11/26 | Ordinary Shares | M行使選擇權取得 | +76,689 | $123.36 | +$9,460,355.04 | 470,021 | 直接 | |
| 2025/11/26 | Ordinary Shares | M行使選擇權取得 | +811 | $123.36 | +$100,044.96 | 470,832 | 直接 | |
| 2025/11/26 | Ordinary Shares | S賣出處分 | −30,487 | $178.06F1 | −$5,428,515.22 | 440,345 | 直接 | |
| 2025/11/26 | Ordinary Shares | S賣出處分 | −8,380 | $179.23F2 | −$1,501,947.4 | 431,965 | 直接 | |
| 2025/11/26 | Ordinary Shares | S賣出處分 | −507 | $179.79F3 | −$91,153.53 | 431,458 | 直接 | |
| 2025/11/26 | Ordinary Shares | S賣出處分 | −38,126 | $177.27F4 | −$6,758,596.02 | 393,332 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/11/26 | Ordinary Shares | M行使選擇權處分 | −811 | $0.00 | $0 | 0 | 直接 | |
| 2025/11/26 | Ordinary Shares | M行使選擇權處分 | −76,689 | $0.00 | $0 | 0 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $177.70 to $178.685. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F2
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $178.72 to $179.705. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $179.73 to $179.96. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $176.70 to $177.69. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
表 I 有 1 筆交易的價格引用這則附註。